The Live Forever Club is evolving. Subscribe to the newsletter to be the first to hear about this important change.

Alexander Hewitson

Chief Operating Officer at Alchemab Therapeutics

Prior to joining Alchemab, Alex held several senior leadership roles within AstraZeneca where he was most recently Head of Operations, ensuring business operations were maintained during the company’s transitional move to Cambridge, leading the business operational activities during the pandemic, and setting operational strategy.   

Prior to joining AstraZeneca, Alex was Programme Director and Head of Campus Delivery Programme for the Biotechnology and Biological Sciences Research Council (BBSRC) where he led the delivery of the UKs National Capability Asset in the form of the high containment laboratories at The Pirbright Institute, and development of the UK Research and Innovation Campuses, through the delivery of key specialist national assets across the BBSRC Estate Portfolio.

Alex is a Chartered Engineer and Chartered Surveyor, and is a Director and Chair of the Audit Committee of Babraham Research Campus in Cambridge. 

Visit website: https://www.alchemab.com/team-member/alexander-hewitson/

 alexander-hewitson-5908aa8

See also

Alchemab Therapeutics

Pioneering the next generation of antibody therapeutics for hard to treat diseases

Details last updated 08-Jan-2025

Alexander Hewitson is also referenced in the following:

Alchemab Therapeutics

Pioneering the next generation of antibody therapeutics for hard to treat diseases

DoNotAge supplements affiliate link